nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—ABCC5—Mercaptopurine—Crohn's disease	0.525	0.675	CbGbCtD
Alprostadil—ABCC4—Mercaptopurine—Crohn's disease	0.252	0.325	CbGbCtD
Alprostadil—Misoprostol—PTGER4—Crohn's disease	0.00745	0.729	CrCbGaD
Alprostadil—Drug ineffective—Mesalazine—Crohn's disease	0.00439	0.0821	CcSEcCtD
Alprostadil—PTGER2—mammalian vulva—Crohn's disease	0.00211	0.133	CbGeAlD
Alprostadil—Dinoprostone—PTGER4—Crohn's disease	0.00209	0.204	CrCbGaD
Alprostadil—Stiffness—Mesalazine—Crohn's disease	0.002	0.0375	CcSEcCtD
Alprostadil—Prostatic disorder—Mesalazine—Crohn's disease	0.00179	0.0335	CcSEcCtD
Alprostadil—PTGIR—epithelium—Crohn's disease	0.00143	0.0898	CbGeAlD
Alprostadil—Local reaction—Mesalazine—Crohn's disease	0.00138	0.0257	CcSEcCtD
Alprostadil—PTGIR—smooth muscle tissue—Crohn's disease	0.00138	0.0866	CbGeAlD
Alprostadil—Micturition urgency—Mesalazine—Crohn's disease	0.00134	0.0251	CcSEcCtD
Alprostadil—SLCO2A1—epithelium—Crohn's disease	0.00125	0.0785	CbGeAlD
Alprostadil—Sepsis—Mercaptopurine—Crohn's disease	0.00122	0.0228	CcSEcCtD
Alprostadil—SLCO2A1—skin of body—Crohn's disease	0.00119	0.0747	CbGeAlD
Alprostadil—Burning sensation—Mesalazine—Crohn's disease	0.0011	0.0205	CcSEcCtD
Alprostadil—SLCO3A1—mammalian vulva—Crohn's disease	0.00109	0.0688	CbGeAlD
Alprostadil—PTGIR—digestive system—Crohn's disease	0.00109	0.0683	CbGeAlD
Alprostadil—SLCO2A1—mammalian vulva—Crohn's disease	0.00108	0.0681	CbGeAlD
Alprostadil—PTGER2—lymph node—Crohn's disease	0.00106	0.0667	CbGeAlD
Alprostadil—Feeling hot—Mesalazine—Crohn's disease	0.000971	0.0181	CcSEcCtD
Alprostadil—Vasodilation—Mesalazine—Crohn's disease	0.000867	0.0162	CcSEcCtD
Alprostadil—Vasodilation procedure—Mesalazine—Crohn's disease	0.000867	0.0162	CcSEcCtD
Alprostadil—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00085	0.0159	CcSEcCtD
Alprostadil—Trauma—Prednisone—Crohn's disease	0.000847	0.0158	CcSEcCtD
Alprostadil—Influenza like illness—Mesalazine—Crohn's disease	0.00074	0.0138	CcSEcCtD
Alprostadil—Hypertriglyceridaemia—Prednisone—Crohn's disease	0.000702	0.0131	CcSEcCtD
Alprostadil—Cramps of lower extremities—Mesalazine—Crohn's disease	0.0007	0.0131	CcSEcCtD
Alprostadil—Multiple fractures—Prednisone—Crohn's disease	0.000694	0.013	CcSEcCtD
Alprostadil—Fracture—Prednisone—Crohn's disease	0.000694	0.013	CcSEcCtD
Alprostadil—Ecchymosis—Mesalazine—Crohn's disease	0.000689	0.0129	CcSEcCtD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS2—Crohn's disease	0.000686	0.0671	CrCbGaD
Alprostadil—SLCO2B1—digestive system—Crohn's disease	0.00068	0.0428	CbGeAlD
Alprostadil—PTGIR—lymph node—Crohn's disease	0.00062	0.039	CbGeAlD
Alprostadil—Blood triglycerides increased—Prednisone—Crohn's disease	0.000615	0.0115	CcSEcCtD
Alprostadil—ABCC4—digestive system—Crohn's disease	0.000602	0.0379	CbGeAlD
Alprostadil—PTGER1—GPCR ligand binding—MLN—Crohn's disease	0.000584	0.00409	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000576	0.00404	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000576	0.00404	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000575	0.00403	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000575	0.00403	CbGpPWpGaD
Alprostadil—Anaemia—Mercaptopurine—Crohn's disease	0.000567	0.0106	CcSEcCtD
Alprostadil—Lethargy—Mesalazine—Crohn's disease	0.000565	0.0105	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—GPR65—Crohn's disease	0.000557	0.00391	CbGpPWpGaD
Alprostadil—SLCO3A1—lymph node—Crohn's disease	0.000547	0.0345	CbGeAlD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000545	0.00383	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000545	0.00383	CbGpPWpGaD
Alprostadil—SLCO2A1—lymph node—Crohn's disease	0.000542	0.0341	CbGeAlD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000535	0.00376	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000531	0.00373	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000531	0.00373	CbGpPWpGaD
Alprostadil—Fungal infection—Prednisone—Crohn's disease	0.000522	0.00975	CcSEcCtD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000521	0.00365	CbGpPWpGaD
Alprostadil—Blood creatinine increased—Mesalazine—Crohn's disease	0.000518	0.00968	CcSEcCtD
Alprostadil—Oedema—Mercaptopurine—Crohn's disease	0.000501	0.00936	CcSEcCtD
Alprostadil—ABCC5—lymph node—Crohn's disease	0.000496	0.0312	CbGeAlD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000494	0.00346	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000494	0.00346	CbGpPWpGaD
Alprostadil—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000491	0.00916	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—MLN—Crohn's disease	0.000488	0.00343	CbGpPWpGaD
Alprostadil—Skin disorder—Mercaptopurine—Crohn's disease	0.000487	0.00909	CcSEcCtD
Alprostadil—Influenza—Mesalazine—Crohn's disease	0.000478	0.00893	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—ACKR2—Crohn's disease	0.000468	0.00328	CbGpPWpGaD
Alprostadil—Bronchitis—Mesalazine—Crohn's disease	0.00046	0.00859	CcSEcCtD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000459	0.00322	CbGpPWpGaD
Alprostadil—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000444	0.0083	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—MLN—Crohn's disease	0.000443	0.00311	CbGpPWpGaD
Alprostadil—Pollakiuria—Mesalazine—Crohn's disease	0.000442	0.00825	CcSEcCtD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000438	0.00308	CbGpPWpGaD
Alprostadil—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000426	0.00796	CcSEcCtD
Alprostadil—Haemoglobin—Azathioprine—Crohn's disease	0.000422	0.00789	CcSEcCtD
Alprostadil—ABCC5—Carbohydrate metabolism—GCKR—Crohn's disease	0.00042	0.00295	CbGpPWpGaD
Alprostadil—Haemorrhage—Azathioprine—Crohn's disease	0.00042	0.00785	CcSEcCtD
Alprostadil—Renal failure—Mesalazine—Crohn's disease	0.000419	0.00783	CcSEcCtD
Alprostadil—Urinary tract infection—Mesalazine—Crohn's disease	0.000414	0.00774	CcSEcCtD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000411	0.00288	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000411	0.00288	CbGpPWpGaD
Alprostadil—Haematuria—Mesalazine—Crohn's disease	0.000406	0.00759	CcSEcCtD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000405	0.00284	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCR9—Crohn's disease	0.000405	0.00284	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCR9—Crohn's disease	0.000405	0.00284	CbGpPWpGaD
Alprostadil—Sinusitis—Mesalazine—Crohn's disease	0.0004	0.00747	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—CCR6—Crohn's disease	0.000397	0.00278	CbGpPWpGaD
Alprostadil—Body temperature increased—Mercaptopurine—Crohn's disease	0.000396	0.0074	CcSEcCtD
Alprostadil—SLCO2B1—lymph node—Crohn's disease	0.000388	0.0244	CbGeAlD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000387	0.00272	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.000385	0.0027	CbGpPWpGaD
Alprostadil—Haemoglobin—Mesalazine—Crohn's disease	0.000385	0.00719	CcSEcCtD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000384	0.00269	CbGpPWpGaD
Alprostadil—Rhinitis—Mesalazine—Crohn's disease	0.000384	0.00717	CcSEcCtD
Alprostadil—Haemorrhage—Mesalazine—Crohn's disease	0.000383	0.00715	CcSEcCtD
Alprostadil—Pharyngitis—Mesalazine—Crohn's disease	0.00038	0.0071	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—GPR65—Crohn's disease	0.000376	0.00264	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—GPR65—Crohn's disease	0.000376	0.00264	CbGpPWpGaD
Alprostadil—Urethral disorder—Mesalazine—Crohn's disease	0.000375	0.00701	CcSEcCtD
Alprostadil—Ecchymosis—Prednisone—Crohn's disease	0.000365	0.00681	CcSEcCtD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000362	0.00254	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000362	0.00254	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000358	0.00251	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000352	0.00247	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000352	0.00247	CbGpPWpGaD
Alprostadil—Sepsis—Prednisone—Crohn's disease	0.00035	0.00654	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—PTGER4—Crohn's disease	0.000349	0.00245	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.000347	0.00243	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.000345	0.00242	CbGpPWpGaD
Alprostadil—ABCC4—lymph node—Crohn's disease	0.000344	0.0216	CbGeAlD
Alprostadil—Diarrhoea—Mercaptopurine—Crohn's disease	0.000343	0.0064	CcSEcCtD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00034	0.00238	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CCR9—Crohn's disease	0.000338	0.00237	CbGpPWpGaD
Alprostadil—Anaemia—Azathioprine—Crohn's disease	0.000338	0.00631	CcSEcCtD
Alprostadil—Diabetes mellitus—Prednisone—Crohn's disease	0.000337	0.00629	CcSEcCtD
Alprostadil—Erythema—Mesalazine—Crohn's disease	0.000333	0.00622	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—MLN—Crohn's disease	0.00033	0.00231	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—MLN—Crohn's disease	0.00033	0.00231	CbGpPWpGaD
Alprostadil—Nervousness—Mesalazine—Crohn's disease	0.000324	0.00604	CcSEcCtD
Alprostadil—Cardiac failure congestive—Prednisone—Crohn's disease	0.000323	0.00603	CcSEcCtD
Alprostadil—Back pain—Mesalazine—Crohn's disease	0.000322	0.00602	CcSEcCtD
Alprostadil—Muscle spasms—Mesalazine—Crohn's disease	0.00032	0.00598	CcSEcCtD
Alprostadil—Injury—Prednisone—Crohn's disease	0.000318	0.00595	CcSEcCtD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000316	0.00222	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000316	0.00222	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—ACKR2—Crohn's disease	0.000316	0.00222	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—ACKR2—Crohn's disease	0.000316	0.00222	CbGpPWpGaD
Alprostadil—Rash—Mercaptopurine—Crohn's disease	0.000316	0.0059	CcSEcCtD
Alprostadil—Dermatitis—Mercaptopurine—Crohn's disease	0.000316	0.0059	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—GPR65—Crohn's disease	0.000315	0.00221	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00031	0.00217	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00031	0.00217	CbGpPWpGaD
Alprostadil—Anaemia—Mesalazine—Crohn's disease	0.000308	0.00575	CcSEcCtD
Alprostadil—Discomfort—Azathioprine—Crohn's disease	0.000308	0.00575	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CCR9—Crohn's disease	0.000307	0.00216	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000302	0.00212	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000302	0.00212	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—F5—Crohn's disease	0.0003	0.0021	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MLN—Crohn's disease	0.0003	0.0021	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MLN—Crohn's disease	0.0003	0.0021	CbGpPWpGaD
Alprostadil—Syncope—Mesalazine—Crohn's disease	0.000299	0.00558	CcSEcCtD
Alprostadil—Lethargy—Prednisone—Crohn's disease	0.000299	0.00558	CcSEcCtD
Alprostadil—Nausea—Mercaptopurine—Crohn's disease	0.000298	0.00556	CcSEcCtD
Alprostadil—Infection—Azathioprine—Crohn's disease	0.000297	0.00554	CcSEcCtD
Alprostadil—Loss of consciousness—Mesalazine—Crohn's disease	0.000293	0.00547	CcSEcCtD
Alprostadil—Thrombocytopenia—Azathioprine—Crohn's disease	0.000292	0.00546	CcSEcCtD
Alprostadil—Cough—Mesalazine—Crohn's disease	0.000291	0.00543	CcSEcCtD
Alprostadil—Skin disorder—Azathioprine—Crohn's disease	0.00029	0.00542	CcSEcCtD
Alprostadil—Hypertension—Mesalazine—Crohn's disease	0.000288	0.00537	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—GPR65—Crohn's disease	0.000286	0.002	CbGpPWpGaD
Alprostadil—Discomfort—Mesalazine—Crohn's disease	0.00028	0.00523	CcSEcCtD
Alprostadil—Hypotension—Azathioprine—Crohn's disease	0.000279	0.00521	CcSEcCtD
Alprostadil—Cardiac arrest—Prednisone—Crohn's disease	0.000278	0.0052	CcSEcCtD
Alprostadil—Dry mouth—Mesalazine—Crohn's disease	0.000277	0.00518	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—ACKR2—Crohn's disease	0.000276	0.00194	CbGpPWpGaD
Alprostadil—Oedema—Mesalazine—Crohn's disease	0.000272	0.00508	CcSEcCtD
Alprostadil—Infection—Mesalazine—Crohn's disease	0.00027	0.00505	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—CCR6—Crohn's disease	0.000268	0.00188	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCR6—Crohn's disease	0.000268	0.00188	CbGpPWpGaD
Alprostadil—Shock—Mesalazine—Crohn's disease	0.000268	0.005	CcSEcCtD
Alprostadil—Hypokalaemia—Prednisone—Crohn's disease	0.000266	0.00498	CcSEcCtD
Alprostadil—Thrombocytopenia—Mesalazine—Crohn's disease	0.000266	0.00497	CcSEcCtD
Alprostadil—Tachycardia—Mesalazine—Crohn's disease	0.000265	0.00496	CcSEcCtD
Alprostadil—Skin disorder—Mesalazine—Crohn's disease	0.000264	0.00493	CcSEcCtD
Alprostadil—Hyperhidrosis—Mesalazine—Crohn's disease	0.000263	0.00491	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—MLN—Crohn's disease	0.000262	0.00184	CbGpPWpGaD
Alprostadil—Hypotension—Mesalazine—Crohn's disease	0.000254	0.00475	CcSEcCtD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000254	0.00178	CbGpPWpGaD
Alprostadil—Sweating increased—Prednisone—Crohn's disease	0.000246	0.0046	CcSEcCtD
Alprostadil—Feeling abnormal—Azathioprine—Crohn's disease	0.000246	0.0046	CcSEcCtD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000241	0.00169	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TAGAP—Crohn's disease	0.00024	0.00168	CbGpPWpGaD
Alprostadil—Dyspepsia—Mesalazine—Crohn's disease	0.000239	0.00447	CcSEcCtD
Alprostadil—ABCC4—Platelet degranulation—ALB—Crohn's disease	0.000237	0.00166	CbGpPWpGaD
Alprostadil—Body temperature increased—Azathioprine—Crohn's disease	0.000236	0.00441	CcSEcCtD
Alprostadil—Abdominal pain—Azathioprine—Crohn's disease	0.000236	0.00441	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—PTGER4—Crohn's disease	0.000236	0.00166	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—PTGER4—Crohn's disease	0.000236	0.00166	CbGpPWpGaD
Alprostadil—Pain—Mesalazine—Crohn's disease	0.000233	0.00434	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—CCR9—Crohn's disease	0.000229	0.0016	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR9—Crohn's disease	0.000229	0.0016	CbGpPWpGaD
Alprostadil—Hyperglycaemia—Prednisone—Crohn's disease	0.000228	0.00426	CcSEcCtD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—Crohn's disease	0.000226	0.00159	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CCR6—Crohn's disease	0.000224	0.00157	CbGpPWpGaD
Alprostadil—Feeling abnormal—Mesalazine—Crohn's disease	0.000224	0.00419	CcSEcCtD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000223	0.00156	CbGpPWpGaD
Alprostadil—Acute coronary syndrome—Prednisone—Crohn's disease	0.000222	0.00415	CcSEcCtD
Alprostadil—Myocardial infarction—Prednisone—Crohn's disease	0.000221	0.00413	CcSEcCtD
Alprostadil—Body temperature increased—Mesalazine—Crohn's disease	0.000215	0.00402	CcSEcCtD
Alprostadil—Abdominal pain—Mesalazine—Crohn's disease	0.000215	0.00402	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000213	0.00149	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—GPR65—Crohn's disease	0.000213	0.00149	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—GPR65—Crohn's disease	0.000213	0.00149	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000209	0.00147	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000209	0.00147	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RSPO3—Crohn's disease	0.000209	0.00147	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL3—Crohn's disease	0.000208	0.00146	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR9—Crohn's disease	0.000208	0.00146	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCR9—Crohn's disease	0.000208	0.00146	CbGpPWpGaD
Alprostadil—Bradycardia—Prednisone—Crohn's disease	0.000206	0.00385	CcSEcCtD
Alprostadil—Diarrhoea—Azathioprine—Crohn's disease	0.000204	0.00382	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CCR6—Crohn's disease	0.000204	0.00143	CbGpPWpGaD
Alprostadil—Haemoglobin—Prednisone—Crohn's disease	0.000204	0.0038	CcSEcCtD
Alprostadil—Haemorrhage—Prednisone—Crohn's disease	0.000202	0.00378	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	0.000201	0.00141	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SEL1L—Crohn's disease	0.000199	0.00139	CbGpPWpGaD
Alprostadil—Dizziness—Azathioprine—Crohn's disease	0.000197	0.00369	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000197	0.00138	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000197	0.00138	CbGpPWpGaD
Alprostadil—Asthenia—Mesalazine—Crohn's disease	0.000195	0.00364	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—GPR65—Crohn's disease	0.000193	0.00135	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—GPR65—Crohn's disease	0.000193	0.00135	CbGpPWpGaD
Alprostadil—Pruritus—Mesalazine—Crohn's disease	0.000192	0.00359	CcSEcCtD
Alprostadil—Rash—Azathioprine—Crohn's disease	0.000188	0.00352	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000188	0.00132	CbGpPWpGaD
Alprostadil—Dermatitis—Azathioprine—Crohn's disease	0.000188	0.00351	CcSEcCtD
Alprostadil—Flushing—Prednisone—Crohn's disease	0.000188	0.00351	CcSEcCtD
Alprostadil—Headache—Azathioprine—Crohn's disease	0.000187	0.00349	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—ACKR2—Crohn's disease	0.000187	0.00131	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ACKR2—Crohn's disease	0.000187	0.00131	CbGpPWpGaD
Alprostadil—Diarrhoea—Mesalazine—Crohn's disease	0.000186	0.00348	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—ITGA4—Crohn's disease	0.000184	0.00129	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR9—Crohn's disease	0.000182	0.00127	CbGpPWpGaD
Alprostadil—Dizziness—Mesalazine—Crohn's disease	0.00018	0.00336	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—IL3—Crohn's disease	0.00018	0.00126	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PTGER4—Crohn's disease	0.000179	0.00126	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—F5—Crohn's disease	0.000179	0.00125	CbGpPWpGaD
Alprostadil—Nausea—Azathioprine—Crohn's disease	0.000177	0.00331	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—MLN—Crohn's disease	0.000177	0.00124	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MLN—Crohn's disease	0.000177	0.00124	CbGpPWpGaD
Alprostadil—Erythema—Prednisone—Crohn's disease	0.000176	0.00329	CcSEcCtD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000176	0.00123	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—RASGRP1—Crohn's disease	0.000174	0.00122	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RSPO3—Crohn's disease	0.000174	0.00122	CbGpPWpGaD
Alprostadil—Rash—Mesalazine—Crohn's disease	0.000171	0.0032	CcSEcCtD
Alprostadil—Dermatitis—Mesalazine—Crohn's disease	0.000171	0.0032	CcSEcCtD
Alprostadil—Headache—Mesalazine—Crohn's disease	0.00017	0.00318	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—GPR65—Crohn's disease	0.000169	0.00118	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—IL3—Crohn's disease	0.000168	0.00118	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000168	0.00118	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000168	0.00118	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PLA2G4F—Crohn's disease	0.000166	0.00117	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SEL1L—Crohn's disease	0.000165	0.00116	CbGpPWpGaD
Alprostadil—Anaemia—Prednisone—Crohn's disease	0.000163	0.00304	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000163	0.00114	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TAGAP—Crohn's disease	0.000162	0.00114	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TAGAP—Crohn's disease	0.000162	0.00114	CbGpPWpGaD
Alprostadil—Nausea—Mesalazine—Crohn's disease	0.000162	0.00302	CcSEcCtD
Alprostadil—Syncope—Prednisone—Crohn's disease	0.000158	0.00295	CcSEcCtD
Alprostadil—Loss of consciousness—Prednisone—Crohn's disease	0.000155	0.00289	CcSEcCtD
Alprostadil—Convulsion—Prednisone—Crohn's disease	0.000153	0.00285	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—IL3—Crohn's disease	0.000153	0.00107	CbGpPWpGaD
Alprostadil—Hypertension—Prednisone—Crohn's disease	0.000152	0.00284	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—CCR6—Crohn's disease	0.000151	0.00106	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR6—Crohn's disease	0.000151	0.00106	CbGpPWpGaD
Alprostadil—Discomfort—Prednisone—Crohn's disease	0.000148	0.00277	CcSEcCtD
Alprostadil—ABCC5—Disease—LTF—Crohn's disease	0.000148	0.00104	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000148	0.00104	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000148	0.00104	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	0.000146	0.00102	CbGpPWpGaD
Alprostadil—Oedema—Prednisone—Crohn's disease	0.000144	0.00269	CcSEcCtD
Alprostadil—Infection—Prednisone—Crohn's disease	0.000143	0.00267	CcSEcCtD
Alprostadil—Shock—Prednisone—Crohn's disease	0.000142	0.00264	CcSEcCtD
Alprostadil—ABCC5—Metabolism—MTMR3—Crohn's disease	0.000142	0.000993	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RSPO3—Crohn's disease	0.000141	0.000992	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RSPO3—Crohn's disease	0.000141	0.000992	CbGpPWpGaD
Alprostadil—Tachycardia—Prednisone—Crohn's disease	0.00014	0.00262	CcSEcCtD
Alprostadil—Skin disorder—Prednisone—Crohn's disease	0.00014	0.00261	CcSEcCtD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00014	0.000979	CbGpPWpGaD
Alprostadil—Hyperhidrosis—Prednisone—Crohn's disease	0.000139	0.0026	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—CCR6—Crohn's disease	0.000138	0.000965	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR6—Crohn's disease	0.000138	0.000965	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SEL1L—Crohn's disease	0.000134	0.000941	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SEL1L—Crohn's disease	0.000134	0.000941	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PTGER4—Crohn's disease	0.000133	0.000935	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000133	0.000935	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00013	0.000915	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000129	0.000905	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—CXCL8—Crohn's disease	0.000128	0.000897	CbGpPWpGaD
Alprostadil—Dyspepsia—Prednisone—Crohn's disease	0.000127	0.00237	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—IL2RA—Crohn's disease	0.000126	0.000883	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR9—Crohn's disease	0.000123	0.00086	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR9—Crohn's disease	0.000123	0.00086	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000122	0.000858	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PTGER4—Crohn's disease	0.000121	0.000849	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PTGER4—Crohn's disease	0.000121	0.000849	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR6—Crohn's disease	0.00012	0.000844	CbGpPWpGaD
Alprostadil—ABCC5—Disease—GCKR—Crohn's disease	0.000119	0.000835	CbGpPWpGaD
Alprostadil—Feeling abnormal—Prednisone—Crohn's disease	0.000119	0.00221	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000118	0.000826	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GPR65—Crohn's disease	0.000114	0.0008	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GPR65—Crohn's disease	0.000114	0.0008	CbGpPWpGaD
Alprostadil—Abdominal pain—Prednisone—Crohn's disease	0.000114	0.00212	CcSEcCtD
Alprostadil—Body temperature increased—Prednisone—Crohn's disease	0.000114	0.00212	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—IL3—Crohn's disease	0.000114	0.000797	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL3—Crohn's disease	0.000114	0.000797	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000113	0.000796	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000113	0.000796	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—FADS1—Crohn's disease	0.00011	0.000773	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00011	0.000771	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00011	0.000771	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ITGA4—Crohn's disease	0.00011	0.000771	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RBX1—Crohn's disease	0.000109	0.000763	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL3—Crohn's disease	0.000107	0.000751	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL2RA—Crohn's disease	0.000107	0.00075	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTGER4—Crohn's disease	0.000106	0.000743	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.000105	0.000738	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SLC11A1—Crohn's disease	0.000105	0.000738	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—RASGRP1—Crohn's disease	0.000104	0.000727	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GPX4—Crohn's disease	0.000103	0.000724	CbGpPWpGaD
Alprostadil—Asthenia—Prednisone—Crohn's disease	0.000103	0.00193	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—IL3—Crohn's disease	0.000103	0.000723	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL3—Crohn's disease	0.000103	0.000723	CbGpPWpGaD
Alprostadil—Pruritus—Prednisone—Crohn's disease	0.000102	0.0019	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—RASGRP1—Crohn's disease	9.97e-05	0.0007	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—RASGRP1—Crohn's disease	9.97e-05	0.0007	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GCKR—Crohn's disease	9.97e-05	0.000699	CbGpPWpGaD
Alprostadil—Diarrhoea—Prednisone—Crohn's disease	9.84e-05	0.00184	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	9.78e-05	0.000686	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—UBE2D1—Crohn's disease	9.54e-05	0.000669	CbGpPWpGaD
Alprostadil—Dizziness—Prednisone—Crohn's disease	9.51e-05	0.00178	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—RIPK2—Crohn's disease	9.25e-05	0.000649	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—ALB—Crohn's disease	9.1e-05	0.000638	CbGpPWpGaD
Alprostadil—Rash—Prednisone—Crohn's disease	9.07e-05	0.00169	CcSEcCtD
Alprostadil—Dermatitis—Prednisone—Crohn's disease	9.06e-05	0.00169	CcSEcCtD
Alprostadil—ABCC5—Disease—RBX1—Crohn's disease	9.02e-05	0.000633	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HSPA1B—Crohn's disease	9.02e-05	0.000633	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL3—Crohn's disease	9.02e-05	0.000633	CbGpPWpGaD
Alprostadil—Headache—Prednisone—Crohn's disease	9.01e-05	0.00168	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—RASGRP1—Crohn's disease	8.72e-05	0.000612	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CXCL8—Crohn's disease	8.64e-05	0.000606	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CXCL8—Crohn's disease	8.64e-05	0.000606	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.6e-05	0.000604	CbGpPWpGaD
Alprostadil—Nausea—Prednisone—Crohn's disease	8.54e-05	0.0016	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—JAK2—Crohn's disease	8.46e-05	0.000594	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR6—Crohn's disease	8.12e-05	0.00057	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR6—Crohn's disease	8.12e-05	0.00057	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2RA—Crohn's disease	7.96e-05	0.000558	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2RA—Crohn's disease	7.96e-05	0.000558	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—JAK2—Crohn's disease	7.92e-05	0.000555	CbGpPWpGaD
Alprostadil—ABCC5—Disease—UBE2D1—Crohn's disease	7.91e-05	0.000555	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SOCS1—Crohn's disease	7.9e-05	0.000554	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TYK2—Crohn's disease	7.54e-05	0.000529	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2RA—Crohn's disease	7.5e-05	0.000526	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RBX1—Crohn's disease	7.35e-05	0.000515	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RBX1—Crohn's disease	7.35e-05	0.000515	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—CXCL8—Crohn's disease	7.22e-05	0.000507	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2RA—Crohn's disease	7.22e-05	0.000507	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2RA—Crohn's disease	7.22e-05	0.000507	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—JAK2—Crohn's disease	7.19e-05	0.000504	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTGER4—Crohn's disease	7.15e-05	0.000502	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTGER4—Crohn's disease	7.15e-05	0.000502	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.09e-05	0.000497	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SMAD3—Crohn's disease	6.82e-05	0.000479	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ALB—Crohn's disease	6.77e-05	0.000475	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CXCL8—Crohn's disease	6.56e-05	0.00046	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—UBE2D1—Crohn's disease	6.44e-05	0.000452	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—UBE2D1—Crohn's disease	6.44e-05	0.000452	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2RA—Crohn's disease	6.32e-05	0.000443	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RIPK2—Crohn's disease	6.25e-05	0.000438	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RIPK2—Crohn's disease	6.25e-05	0.000438	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL3—Crohn's disease	6.09e-05	0.000427	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL3—Crohn's disease	6.09e-05	0.000427	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RASGRP1—Crohn's disease	5.89e-05	0.000413	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RASGRP1—Crohn's disease	5.89e-05	0.000413	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SMAD3—Crohn's disease	5.66e-05	0.000397	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ALB—Crohn's disease	5.42e-05	0.000381	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—JAK2—Crohn's disease	5.35e-05	0.000375	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—JAK2—Crohn's disease	5.35e-05	0.000375	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SOCS1—Crohn's disease	5.34e-05	0.000375	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SOCS1—Crohn's disease	5.34e-05	0.000375	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TYK2—Crohn's disease	5.09e-05	0.000357	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TYK2—Crohn's disease	5.09e-05	0.000357	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—JAK2—Crohn's disease	5.04e-05	0.000354	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL8—Crohn's disease	4.88e-05	0.000342	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL8—Crohn's disease	4.88e-05	0.000342	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—JAK2—Crohn's disease	4.86e-05	0.000341	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—JAK2—Crohn's disease	4.86e-05	0.000341	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ALB—Crohn's disease	4.7e-05	0.000329	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SMAD3—Crohn's disease	4.61e-05	0.000323	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SMAD3—Crohn's disease	4.61e-05	0.000323	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TYK2—Crohn's disease	4.45e-05	0.000312	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL8—Crohn's disease	4.43e-05	0.000311	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL8—Crohn's disease	4.43e-05	0.000311	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2RA—Crohn's disease	4.27e-05	0.000299	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2RA—Crohn's disease	4.27e-05	0.000299	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—JAK2—Crohn's disease	4.25e-05	0.000298	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL8—Crohn's disease	3.88e-05	0.000272	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TYK2—Crohn's disease	3.69e-05	0.000259	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—Crohn's disease	3.69e-05	0.000259	CbGpPWpGaD
Alprostadil—ABCC5—Disease—JAK2—Crohn's disease	3.52e-05	0.000247	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD4—Crohn's disease	3.34e-05	0.000234	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—Crohn's disease	3.31e-05	0.000233	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ALB—Crohn's disease	3.17e-05	0.000223	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—STAT3—Crohn's disease	3.12e-05	0.000219	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TYK2—Crohn's disease	3.01e-05	0.000211	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TYK2—Crohn's disease	3.01e-05	0.000211	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—JAK2—Crohn's disease	2.87e-05	0.000201	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—JAK2—Crohn's disease	2.87e-05	0.000201	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—Crohn's disease	2.78e-05	0.000195	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL8—Crohn's disease	2.62e-05	0.000184	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL8—Crohn's disease	2.62e-05	0.000184	CbGpPWpGaD
Alprostadil—ABCC5—Disease—STAT3—Crohn's disease	2.59e-05	0.000181	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—Crohn's disease	2.49e-05	0.000175	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—Crohn's disease	2.49e-05	0.000175	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—Crohn's disease	2.18e-05	0.000153	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STAT3—Crohn's disease	2.11e-05	0.000148	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STAT3—Crohn's disease	2.11e-05	0.000148	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—Crohn's disease	1.81e-05	0.000127	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—Crohn's disease	1.47e-05	0.000103	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—Crohn's disease	1.47e-05	0.000103	CbGpPWpGaD
